DOSSIER · 13F-HR · Q2 2026

Checkpoint Capital L.P.

$390M in tracked AUM across 6 positions as of Q2 2026.

CC
CIK 0001977548 · last filed Jun 30, 2026
Total AUM
$390M
as of Q2 2026
Holdings
6
positions
Whale Score
71
71
strong
Activity
no data
changes this Q
AI Analysis · Q2 2026
Comprehensive Analysis of Checkpoint Capital L.P. 13F Filing (Q3 2025)
1. Portfolio Overview

Checkpoint Capital L.P. manages a highly concentrated, specialized investment portfolio totaling approximately $233.96 million as of September 30, 2025. The firm demonstrates a distinct "high-conviction" strategy, evidenced by the extremely low number of holdings (7) and the significant allocation weighting to top positions.

The portfolio experienced robust growth during the quarter, increasing i...

2. Key Holdings

The portfolio is dominated by a "barbell" of two massive positions that constitute over 80% of the total assets:

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
RYTM
RHYTHM PHARMACEUTICALS INC
$132M1.2M33.8%
02
ARGX
ARGENX SE
$122M131K31.3%
03
RVMD
REVOLUTION MEDICINES INC
$77M410K19.7%
04
CYTK
CYTOKINETICS INC
$40M475K10.4%
05
IRON
DISC MEDICINE INC
$18M240K4.5%
06
TRVI
TREVI THERAPEUTICS INC
$1M75K0.4%

Filing history

2026Q2Jun 30
$390M 39.9%
6 positionsView →
2026Q1Mar 31
$279M 12.9%
8 positionsView →
2025Q4Dec 31
$320M 36.8%
7 positionsView →
2025Q3Sep 30
$234M 9.0%
7 positionsView →
2025Q2Jun 30
$215M 50.4%
8 positionsLocked
2025Q1Mar 31
$143M 27.4%
7 positionsLocked
2024Q4Dec 31
$196M 2.5%
16 positionsLocked
2024Q3Sep 30
$202M 21.5%
16 positionsLocked
2024Q2Jun 30
$166M 10.9%
16 positionsLocked
2024Q1Mar 31
$150M 9.4%
17 positionsLocked
2023Q4Dec 31
$165M
19 positionsLocked